QuickSTAT has seen a marked growth in clinical trial shipments to and from Latin American countries. To accommodate this growth, QuickSTAT has been making significant investments to enhance logistics capabilities in the region.
New York, NY (PRWEB) April 28, 2016
As part of an ongoing global expansion plan, QuickSTAT has made significant investments in recruiting top industry experts, and expanding its LATAM network and logistics capabilities. Enhancements have been made to its IT Platform, which provides industry-leading tools for clients to manage their clinical trial projects.
The expansion will provide unmatched clinical trial logistics services for the pharmaceutical and biotech companies conducting clinical trials in the region.
Since 2008, Latin America has been one of the fastest growing pharmaceutical markets in the world, driven by generic drugs manufactured by local companies and biosimilars manufactured both by multinational and local pharmaceutical companies.
QuickSTAT has seen a marked growth in clinical trial and clinical trial supply shipments shipments to and from Latin American countries. To accommodate this growth, QuickSTAT has been making significant investments to enhance logistics capabilities in the region. Highlights include:
- Highly Experienced Clinical Trial Logistics Team in LATAM--Top industry specialists have been added to the global QuickSTAT team, each with over 20 years of experience developing clinical trial logistics solutions in LATAM for investigators, CROs, Pharmaceutical and Biotech companies. These specialists have designed customized supply chain solutions for all phases of research and drug development.
- Additional Regional Offices --QuickSTAT has opened two additional operational and customer support offices dedicated to serve the region in Buenos Aires, Argentina and in Miami, Florida. Specially trained customer service and operations teams, fluent in the local language, provide 24/7 transportation and logistics services, as well as in-transit storage for patient-clinical specimens, API, vaccines and investigational drugs, utilizing GDP principles and best practices.
- Regional Regulatory Support --Regulatory requirements continue to be one of the main challenges for the transport of pharmaceuticals throughout the region. To help clients navigate through this ever-changing and complex regulatory environment, QuickSTAT provides brokerage services, as well as regulatory support for import and export of biologics, samples, kits, drugs, medical devices and supplies related to clinical trials to and from LATAM, US, Europe and throughout the world.
- Close Relationship with Local Regulatory Agencies--Strong relationships have been developed and maintained with the principal regulatory agencies such as Anvisa, ANMAT, Cofepris, Digemid, and Unimed, which allows QuickSTAT to provide up-to-the-minute information to their clients on regulatory changes in the region.
- Enhancements to Technology Platform and Online Client Tools--Upgrades have been made to QuickOnlineRX, an advanced IT tool designed specifically for clinical trials, to help clients manage their clinical supply chain. Due to its robust capabilities and ease of use, 85% of clients utilize QuickOnlineRX to monitor supply chain activity, obtain real-time shipment information and check temperature integrity throughout transit.
“Our investment in an increased global footprint in Latin America, the recruitment of top industry specialists, along with our market-leading IT platform demonstrates our commitment to the Life Science community in the region. We are very excited about the enhanced solutions and tools we can provide ” says Dominique Brown, COO, QuickSTAT.
For over 35 years, QuickSTAT has managed multinational biopharmaceutical clinical trial logistics for all phases of research and drug development, for all temperature ranges and life science products. QuickSTAT specializes in time and temperature shipping of clinical research samples, biologics, investigational drugs, clinical trial supplies, vaccines and dangerous goods, helping to bring important new drugs and medical protocols to market faster.